搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
4 天
Avidity Biosciences: Good Prospects, But We Are A Little Late
Avidity Biosciences excels in antibody oligonucleotide conjugates with its stock tripling in the past year due to innovative ...
5 天
Avidity Biosciences Announces FDA Removed Partial Clinical Hold on Delpacibart Etedesiran ...
Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics ...
5 天
A Game-Changer: Commonly Used Drug Could Transform Treatment of Rare Muscle Disorder
A UCL study found that lamotrigine is as effective as mexiletine for treating non-dystrophic myotonia, a rare muscle disorder ...
inceptivemind
5 天
What should declining Japanese cities do?
Aging societies and population decline have been on the rise globally. However, the factors that correlate with population ...
The Brighterside of News on MSN
6 天
Commonly used drug could revolutionize treatment of rare muscle disorder
This latest research on non-dystrophic myotonia offers promising results for those affected by the condition. Published in ...
News Medical
7 天
Drug Trial News
In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic ...
technologynetworks
8 天
Commonly Used Drug Could Be Promising Treatment Option for Rare Muscle Disorder
A study tested the effectiveness of mexiletine and lamotrigine in treating non-dystrophic myotonia. Results indicated that ...
inceptivemind
8 天
A promising solution for non-dystrophic myotonia
Lamotrigine, commonly used for epilepsy and mood disorders, has shown promise as a treatment for non-dystrophic myotonia, a ...
Knowridge
9 天
Epilepsy drug offers new hope for rare muscle disorder
A common drug used to treat epilepsy and certain mood disorders, called lamotrigine, has shown great promise as a new ...
Daily
10 天
Lupin arm ink pact with Celnova for distribution of Orphan Drug NaMuscla in Argentina, Colombia
Mumbai: Global pharma major, Lupin Limited has announced that its subsidiary Lupin Atlantis Holdings SA has entered into a ...
News Medical on MSN
10 天
A randomized trial of mexiletine and lamotrigine in adults with non-dystrophic myotonia
The study, published in Lancet Neurology , detailed the "head-to-head" trial implemented by the researchers to test two drugs ...
techexplorist
10 天
A new hope for patients with non-dystrophic myotonia
Lamotrigine, a drug used for epilepsy and mood disorders, was found to be a good treatment for a rare muscle disease called ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈